The US federal government is aiming to save $8.4 billion over the next five years by reducing payments to pharmacies for dispensing drugs under the Medicaid program.
The new regulation ensures that Medicaid can obtain prescription drugs at the same reduced prices as those obtained by pharmacy benefit managers or mail-order pharmacies, according to the Department of Health and Human Services. The effect could be to hit revenues for smaller pharmacies especially hard, according to the North Carolina-headquartered Association of Community Pharmacists Congressional Network. A spokesman for the ACP*CN said: "the federal government seems determined to annihilate the best medication delivery system in the world with its latest ill-conceived cost savings plan."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze